Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical experience with carvedilol

M Moser1

  • 1Yale University School of Medicine, New Haven, Connecticut.

Journal of Human Hypertension
|February 1, 1993
PubMed
Summary
This summary is machine-generated.

Carvedilol, a beta-blocker, shows effectiveness as a once-daily monotherapy for hypertension in young and elderly patients. This well-tolerated drug offers simple titration and comparable response rates to other initial therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combination therapy for hypertension: an update.

Journal of clinical hypertension (Greenwich, Conn.)·2003
Same author

Selection based on morphological assessment of oocytes and embryos at different stages of preimplantation development: a review.

Human reproduction update·2003
Same author

Developmental competence of oocytes showing increased cytoplasmic viscosity.

Human reproduction (Oxford, England)·2003
Same author

Signal recognition particle-dependent protein targeting, universal to all kingdoms of life.

Reviews of physiology, biochemistry and pharmacology·2003
Same author

[Otorhinolaryngologic diseases and flying].

Wiener medizinische Wochenschrift (1946)·2002
Same author

First polar body morphology and blastocyst formation rate in ICSI patients.

Human reproduction (Oxford, England)·2002
Same journal

Mindfulness based interventions for blood pressure reduction: systematic and umbrella review of existing meta-analyses.

Journal of human hypertension·2026
Same journal

Invasive observation of reactive systolic blood pressure responses to upper-arm cuff inflation.

Journal of human hypertension·2026
Same journal

Association between post-thrombectomy blood pressure trajectories and clinical outcomes in hypertensive patients with acute ischemic stroke: a retrospective cohort study.

Journal of human hypertension·2026
Same journal

Systemic inflammation indices generated from first-trimester blood tests can be potential biomarkers for predicting preeclampsia.

Journal of human hypertension·2026
Same journal

Chronotherapy in hypertension: a systematic review and meta-analysis of antihypertensive dosing timing on cardiovascular outcomes.

Journal of human hypertension·2026
Same journal

Effect of relative handgrip strength and back muscle strength on the incidence of hypertension: 18-year follow-up in a population-based cohort study.

Journal of human hypertension·2026
See all related articles

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Hypertension management requires effective and well-tolerated antihypertensive agents.
  • Beta-blockers with vasodilating properties represent a therapeutic option.

Purpose of the Study:

  • To evaluate the efficacy of carvedilol as a once-daily monotherapy for hypertension.
  • To assess the tolerability and response rates of carvedilol in diverse patient populations.

Main Methods:

  • Clinical experience with carvedilol in hypertensive patients (young and elderly).
  • Assessment of once-daily monotherapy efficacy and titration simplicity.
  • Evaluation of patient tolerability and short-term metabolic effects.

Main Results:

  • Carvedilol demonstrates effectiveness as a once-daily monotherapy for both young and elderly hypertensives.

Related Experiment Videos

  • Simple dose titration leads to effective therapeutic levels.
  • Response rates are comparable to other recommended monotherapeutic agents.
  • The drug is generally well-tolerated with no significant short-term metabolic changes.

    • Conclusions:

    • Carvedilol is a viable and effective once-daily monotherapy option for hypertension.
    • Its favorable tolerability and simple titration profile support its use in clinical practice.
    • Further research is warranted to establish long-term effectiveness.